SciLifeLab Anubis

Submit proposals for grants in open calls.


The DDD platform at SciLifeLab supports academic drug discovery project with expertise and technical capabilities. We have, for example, platforms to develop small molecule drugs, therapeutic antibodies, oligonucleotide therapeutics, proximity-inducing agents such as bispecific antibodies and PROTACs. The DDD offer includes full infrastructure support, a competitive/generous cost model, and full retention of ownership for the project proposer (the academic PI).

In this call, the Drug Discovery and Development Platform (DDD) at SciLifeLab is looking for new project proposals for drug discovery. All therapeutic modalities outlined above are of interest. DDD supports a project portfolio consisting of about 20 programs and we foresee a need to replenish our portfolio with 3-5 new programs this year. We are interested in programs with defined targets for diseases with medical needs. Therapeutic ideas based on technologies that can be extended to other targets and/or other indications are of special interest, i.e. therapeutic platform technologies, as are projects to develop therapeutic molecules with innovative mode-of-actions (e.g., targeted delivery or new modes-of-action for antisense oligonucleotides, small molecules, antibodies and/or proximity-inducers).

Note that small projects for selections in phage display libraries for antibodies, selections in DNA encoded chemical libraries for small molecules or limited screening for antisense or siRNA molecules can be considered.

A description of new modalities in drug discovery research can be found here:

If you have questions about the call please contact DDD by email ( This call is open for scientists with a doctoral degree at a Swedish university or higher institution. English should be used when filling out this application. You are responsible for ensuring that the application is complete. Incomplete applications will not be processed.

PALS call no 2 (2024)

81 days remaining.

This call is part of the PALS initiative, supported by the Knut and Alice Wallenberg Foundation.

With this call, PALS wants to support and promote scientific interactions between fellows from the different PALS programs and/or from different organisations within PALS. The supported collaborations can involve either a Research project or an Event in all areas of the different programs such as molecular medicine or different areas of life science and can be technology-driven or data-driven projects from fundamental, preclinical, translational, and clinical scientists.

The supported Research projects should:

  • Have excellent scientific quality, novelty and originality
  • Include multi-disciplinary or translational approaches
  • Have potential future or long-term impact
  • Build on potential synergies in the planned collaboration
  • Merit ideas and align with the goals of PALS

The supported Event in Sweden (eg scientific meetings, summer schools or training/workshop), organized and coordinated jointly by the fellows, should:

  • Have excellent scientific quality, novelty and originality
  • Impact for the PALS community
  • Have a clear aim

This annual call will support collaborations with 100.000 - 250.000 SEK (including indirect costs), the total annual sum awarded is 2MSEK.

For a full description of the call, see

SciLifeLab aims to support events within the scope of our fields of research, open to participants from all over Sweden. We aim to encourage collaboration among and between SciLifeLab infrastructure and researchers, as well as with external organizations, and increase awareness of SciLifeLab to the broader research community in Sweden and abroad. A SciLifeLab infrastructure platform/unit or a SciLifeLab group leader must be the organizer or a visible co-organizer.

Detailed information about the call can be found in this document

No cookies are used.
Anubis 2.9.0